Basic information
Biomarker: AgNORs
Histology type: endometrial carcinoma
Stage: early stage
Cohort characteristics
Country: Argentina
Region: Buenos Aires
Study type: prospective study
Followed up time :
| Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
|---|---|---|---|---|---|---|---|---|
| 13 | EC | 3 | cervical cancer | 10 |
Sample information
Conclusion: AgNORs as an early marker of sensitivity to radiotherapy in gynecologic cancer
Sample type : tissue
Sample method: silver stained
Expression pattern : PI ≥ 150
Expression elevation: AgNORs were counted in 100 nuclei of silverstained cell smears under a light microscope at a magnification of 400 ×. AgNORs were counted in keeping with the methods of Crocker et al and Aubele et al. Fifty normal cervical smear samples were evaluated the same way.(PI = preradiotherapy AgNOR counts ×% reduction in AgNOR counts after the first fraction.)
Disease information
Related information
UniProt Link:
Molecular function from UniProt:
